Skip to main content

Advertisement

Log in

Molecular characterization of bovine CD26 upregulated by a staphylococcal superantigen

  • Brief Communication
  • Published:
Immunogenetics Aims and scope Submit manuscript

Abstract.

In this report, we describe the cloning, sequencing, and expression of the bovine orthologue of CD26 (BoCD26). Several monoclonal antibodies specific for a molecule, activation molecule 3 (ACT3), aberrantly expressed on superantigen-stimulated bovine CD8+ lymphocytes, reacted with recombinant BoCD26 expressed in COS-7 and CHO cells. We also showed that human CD8+ T cells stimulated by a superantigen expressed CD26 at high levels. These results demonstrate that ACT3 is identical to BoCD26 and suggest that CD26 upregulation on CD8+ T cells is a general phenomenon of superantigens and not limited to their effects on bovine cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Additional information

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, SU., Park, YH., Davis, W.C. et al. Molecular characterization of bovine CD26 upregulated by a staphylococcal superantigen. Immunogenetics 54, 216–220 (2002). https://doi.org/10.1007/s00251-002-0456-6

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00251-002-0456-6

Navigation